Literature DB >> 19057323

Surgical management and case-fatality rates of intracerebral hemorrhage in 1988 and 2005.

Opeolu Adeoye1, Daniel Woo, Mary Haverbusch, Padmini Sekar, Charles J Moomaw, Joseph Broderick, Matthew L Flaherty.   

Abstract

OBJECTIVE: To compare surgical management and case-fatality rates of intracerebral hemorrhage (ICH) in 1988 and 2005.
METHODS: We identified all adult residents (age, >or=18 years) from the 5-county Greater Cincinnati region who were hospitalized with ICH in 1988 and 2005. Demographics, severity of illness, ICH volume, ICH location, rates and timing of surgery, and 30-day case-fatality rate were compared between the groups.
RESULTS: In 1988, 171 ICH patients (67 lobar, 80 deep cerebral, 10 brainstem, and 14 cerebellar) met the study criteria; in 2005, 259 ICH patients (91 lobar, 123 deep cerebral, 19 brainstem, and 26 cerebellar) met the study criteria. In 1988, 16% of the patients had surgical removal of their ICH versus 7% in 2005 (P = 0.003). In both 1988 and 2005, patients treated with surgery were younger (P < 0.001) and had a higher percentage of cerebellar hemorrhages than nonsurgical patients. The timing of surgery was similar in 1988 and 2005. In 1988, the 30-day case-fatality rate was 32% in surgical patients versus 50% in nonsurgical patients (P = 0.06). In 2005, the 30-day case-fatality rate was 16% (surgical) versus 45% (nonsurgical) (P = 0.02).
CONCLUSION: The frequency of surgery for ICH was lower in 2005 than in 1988, which may reflect the influence of recent clinical trial data showing no benefit for surgery rather than medical management. The ICH case-fatality rate was essentially the same in 1988 and 2005. Innovative clinical trials to improve ICH outcomes are warranted.

Entities:  

Mesh:

Year:  2008        PMID: 19057323      PMCID: PMC2717618          DOI: 10.1227/01.NEU.0000330414.56390.DE

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  17 in total

1.  Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy.

Authors:  Jun Morioka; Masami Fujii; Shoichi Kato; Hirosuke Fujisawa; Tatsuo Akimura; Michiyasu Suzuki; Shotai Kobayashi
Journal:  Surg Neurol       Date:  2006-01

2.  The increasing incidence of anticoagulant-associated intracerebral hemorrhage.

Authors:  M L Flaherty; B Kissela; D Woo; D Kleindorfer; K Alwell; P Sekar; C J Moomaw; M Haverbusch; J P Broderick
Journal:  Neurology       Date:  2007-01-09       Impact factor: 9.910

3.  Racial variations in location and risk of intracerebral hemorrhage.

Authors:  Matthew L Flaherty; Daniel Woo; Mary Haverbusch; Padmini Sekar; Jane Khoury; Laura Sauerbeck; Charles J Moomaw; Alexander Schneider; Brett Kissela; Dawn Kleindorfer; Joseph P Broderick
Journal:  Stroke       Date:  2005-03-24       Impact factor: 7.914

4.  Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial.

Authors:  A David Mendelow; Barbara A Gregson; Helen M Fernandes; Gordon D Murray; Graham M Teasdale; D Terence Hope; Abbas Karimi; M Donald M Shaw; David H Barer
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

5.  Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study.

Authors:  M Zuccarello; T Brott; L Derex; R Kothari; L Sauerbeck; J Tew; H Van Loveren; H S Yeh; T Tomsick; A Pancioli; J Khoury; J Broderick
Journal:  Stroke       Date:  1999-09       Impact factor: 7.914

6.  Long term survival after primary intracerebral haemorrhage: a retrospective population based study.

Authors:  R Fogelholm; K Murros; A Rissanen; S Avikainen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

7.  Early surgical treatment vs conservative management for spontaneous supratentorial intracerebral hematomas: A prospective randomized study.

Authors:  Georgios Pantazis; Parmenion Tsitsopoulos; Constantinos Mihas; Vasiliki Katsiva; Vasilios Stavrianos; Stylianos Zymaris
Journal:  Surg Neurol       Date:  2006-11

8.  Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group.

Authors:  Joseph Broderick; Sander Connolly; Edward Feldmann; Daniel Hanley; Carlos Kase; Derk Krieger; Marc Mayberg; Lewis Morgenstern; Christopher S Ogilvy; Paul Vespa; Mario Zuccarello
Journal:  Stroke       Date:  2007-05-03       Impact factor: 7.914

9.  The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites.

Authors:  J P Broderick; T Brott; T Tomsick; G Huster; R Miller
Journal:  N Engl J Med       Date:  1992-03-12       Impact factor: 91.245

10.  Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial.

Authors:  L B Morgenstern; R F Frankowski; P Shedden; W Pasteur; J C Grotta
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

View more
  10 in total

Review 1.  Advances in the management of intracerebral hemorrhage.

Authors:  Opeolu Adeoye; Joseph P Broderick
Journal:  Nat Rev Neurol       Date:  2010-09-28       Impact factor: 42.937

2.  Full medical support for intracerebral hemorrhage.

Authors:  Lewis B Morgenstern; Darin B Zahuranec; Brisa N Sánchez; Kyra J Becker; Madeleine Geraghty; Rebecca Hughes; Gregory Norris; J Claude Hemphill
Journal:  Neurology       Date:  2015-03-27       Impact factor: 9.910

3.  Effect of two Chinese medicinal compounds, blood-activating and water-draining medicine, on tumor necrosis factor α and nuclear factor κ B expressions in rats with intracerebral hemorrhage.

Authors:  Yu-Bo Li; Xiang-Ning Cui; Yan Li; Lin Pan; Jian-Yan Wen
Journal:  Chin J Integr Med       Date:  2012-02-27       Impact factor: 1.978

4.  Trends in surgical management and mortality of intracerebral hemorrhage in the United States before and after the STICH trial.

Authors:  Opeolu Adeoye; Andrew Ringer; Richard Hornung; Pooja Khatri; Mario Zuccarello; Dawn Kleindorfer
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

5.  Minimally Invasive Neurosurgery for Spontaneous Intracerebral Hemorrhage-10 Years of Working Progress at National Taiwan University Hospital.

Authors:  Chiu-Hao Hsu; Sheng-Chieh Chou; Lu-Ting Kuo; Sheng-Jean Huang; Shih-Hung Yang; Dar-Ming Lai; Abel Po-Hao Huang
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

6.  Infratentorial strokes for posterior circulation folks: clinical correlations for current translational therapeutics.

Authors:  Tim Lekic; Paul R Krafft; Jacqueline S Coats; Andre Obenaus; Jiping Tang; John H Zhang
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

7.  Randomized trial to assess safety and clinical efficacy of intensive blood pressure reduction in acute spontaneous intracerebral haemorrhage.

Authors:  Salil Gupta; A K Abbot; R Srinath; A K Tewari; Aditya Gupta; S P Gorthi; C S Narayanan; S I Totlani; Y S Sirohi; Ravi Anadure
Journal:  Med J Armed Forces India       Date:  2017-05-18

8.  Current management of intracerebral haemorrhage in China: a national, multi-centre, hospital register study.

Authors:  Jade W Wei; Yining Huang; Ji-Guang Wang; Ming Liu; Lawrence K S Wong; Qifang Huang; Li'e Wu; Emma L Heeley; Hisatomi Arima; Craig S Anderson
Journal:  BMC Neurol       Date:  2011-01-30       Impact factor: 2.474

Review 9.  Posterior circulation stroke: animal models and mechanism of disease.

Authors:  Tim Lekic; Chizobam Ani
Journal:  J Biomed Biotechnol       Date:  2012-05-14

Review 10.  When the Blood Hits Your Brain: The Neurotoxicity of Extravasated Blood.

Authors:  Jesse A Stokum; Gregory J Cannarsa; Aaron P Wessell; Phelan Shea; Nicole Wenger; J Marc Simard
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.